TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8546737

Group type: EXPERIMENTAL
Intervention: 1 mg/day oral bovine type II collagen (n = 30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 10 mg/day oral bovine type II collagen (n = 30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (n = 30)
Number of subjects: 90
Study: 2063598

Group type: EXPERIMENTAL
Intervention: 3 x 200 mg trapidil daily for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: 3 x 200 mg pentoxifylline daily for 6 weeks
Number of subjects: 20
Study: 6380607

Group type: EXPERIMENTAL
Intervention: Nocardia rubra cell‐wall skeleton (N‐CWS)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 190
Study: 30328108

Group type: EXPERIMENTAL
Intervention: Brodalumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 0
Study: 29945150

Group type: EXPERIMENTAL
Intervention: Podiatry intervention including foot and ankle strengthening exercises, foot orthoses, new footwear if required, and a falls prevention leaflet
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Usual podiatry treatment plus a falls prevention leaflet
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Podiatry intervention
Number of subjects: 1010
Study: 28078862

Group type: EXPERIMENTAL
Intervention: Proprietary multi‐ingredient lipid‐lowering supplement (PMILLS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23417235

Group type: EXPERIMENTAL
Intervention: Abbreviated Coping Power program (24 child sessions, 10 parent sessions)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Booster intervention (brief monthly individual contacts primarily with the children)
Number of subjects: 241
Study: 19582386

Group type: EXPERIMENTAL
Intervention: Transobturatory sling technique
Number of subjects: 41

Group type: COMPARATOR
Intervention: Aponeurotic retropubic sling technique
Number of subjects: 41
Study: 15793181

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 3187

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3187

Group type: EXPERIMENTAL
Intervention: Overall DPP participation
Number of subjects: 3187
Study: 12204928

Group type: EXPERIMENTAL
Intervention: Self-help with four sessions of face-to-face guidance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-help with telephone guidance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-help (general)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting-list comparison group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guided self-help
Number of subjects: 0
Study: 9159363

Group type: EXPERIMENTAL
Intervention: Patients with brain tumors and paresis
Number of subjects: 7

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 7
Study: 7943590

Group type: COMPARATOR
Intervention: Truncal vagotomy with pyloroplasty (TVP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Antiulcer operations excluding the duodenum (TV-GJ and Billroth II)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Truncal vagotomy with gastrojejunostomy (TV-GJ)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Billroth II gastrectomy
Number of subjects: 26
Study: 2854781

Group type: EXPERIMENTAL
Intervention: Adjuvant intraluminal 5-FU chemotherapy and intravenous 5-FU chemotherapy (30 mg/kg intraluminally and 10 mg/kg intravenously on the first and second days postoperatively)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (radical resection alone)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Adjuvant intraluminal 5-FU chemotherapy
Number of subjects: 82
Study: 10972454

Group type: EXPERIMENTAL
Intervention: Women smokers
Number of subjects: 136
Study: 30299412

Group type: EXPERIMENTAL
Intervention: Sucrose (SUC; 40 g)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sodium nitrate (NIT; 800 mg NO3)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Water placebo (PLA)
Number of subjects: 16
Study: 29188740

Group type: EXPERIMENTAL
Intervention: Standard clinical CI
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Formal auditory training
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tinnitus specific electrical stimulation
Number of subjects: 10
Study: 27095106

Group type: EXPERIMENTAL
Intervention: Feedback (FB) condition
Number of subjects: 370

Group type: COMPARATOR
Intervention: Treatment‐as‐Usual (TAU) condition
Number of subjects: 370
Study: 24648401

Group type: EXPERIMENTAL
Intervention: Not applicable (observational study)
Number of subjects: 45134
Study: 21911051

Group type: EXPERIMENTAL
Intervention: Bu‐Fei Yi‐Shen granule combined with Shu‐Fei Tie acupoint sticking therapy
Number of subjects: 244

Group type: COMPARATOR
Intervention: Oral sustained‐release theophylline and placebo Bu‐Fei Yi‐Shen granule combined with placebo Shu‐Fei Tie acupoint sticking therapy
Number of subjects: 244
Study: 20416454

Group type: EXPERIMENTAL
Intervention: Pharyngeal packing (Group 1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No pharyngeal packing (Group 2)
Number of subjects: 100
Study: 17413560

Group type: EXPERIMENTAL
Intervention: Diacontrol (DC, plasma conductivity targeted feedback system)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard dialysis (HD)
Number of subjects: 10
Study: 15370670

Group type: EXPERIMENTAL
Intervention: DTPa-HBV-IPV/Hib combined vaccine (Group 1)
Number of subjects: 440

Group type: COMPARATOR
Intervention: DTPa-HBV-IPV (Group 2) and Hib vaccines administered separately
Number of subjects: 440
Study: 11207630

Group type: EXPERIMENTAL
Intervention: Peroral oestradiol valerate 2 mg/day
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta‐oestradiol gel (1 mg oestradiol/day)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 79
Study: 9743769

Group type: EXPERIMENTAL
Intervention: Portfolio learning intervention where students followed a patient with cancer for 9 months, supported by bi-monthly small-group tutorials.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Students submitting portfolios for formative assessment.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard curriculum (Control group).
Number of subjects: 0
Study: 7803676

Group type: EXPERIMENTAL
Intervention: Individualised physical exercise program (walking, frequency, length, intensity calculated individually)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Individualised physical exercise program
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 96
Study: 3058974

Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg, 3 times a day
Number of subjects: 59

Group type: COMPARATOR
Intervention: Indomethacin 50 mg, 3 times a day
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 59

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 59
Study: 30341842

Group type: EXPERIMENTAL
Intervention: Lactulose and rifaximin
Number of subjects: 96

Group type: COMPARATOR
Intervention: Lactulose only (placebo)
Number of subjects: 96
Study: 29202488

Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 26316499

Group type: EXPERIMENTAL
Intervention: Immersive app (Zombies, Run)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Nonimmersive app (Get Running)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (usual behavior)
Number of subjects: 51
Study: 23180385

Group type: EXPERIMENTAL
Intervention: Harmony(®) self‐ligating lingual appliances
Number of subjects: 7

Group type: COMPARATOR
Intervention: Incognito(®) lingual appliances
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Typodonts with Harmony(®) self‐ligating appliances
Number of subjects: 7

Group type: COMPARATOR
Intervention: Typodonts with Incognito(®) appliances
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Self‐ligation
Number of subjects: 7

Group type: COMPARATOR
Intervention: Non-self‐ligation
Number of subjects: 7
Study: 22027699

Group type: EXPERIMENTAL
Intervention: 8 mg Zeaxanthin (Zx)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 9 mg Lutein (L) (Faux Placebo, control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 8 mg Zx plus 9 mg L
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups (Zx, Zx + L, and L)
Number of subjects: 60
Study: 18781089

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 21
Study: 16571852

Group type: EXPERIMENTAL
Intervention: Tailored expert system
Number of subjects: 2862

Group type: COMPARATOR
Intervention: Information-only condition
Number of subjects: 2862
Study: 15543394

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 93

Group type: COMPARATOR
Intervention: Low sodium diet (Control)
Number of subjects: 93
Study: 11203846

Group type: EXPERIMENTAL
Intervention: Dyract (DeTrey‐Dentsply) with etching for 30 seconds
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dyract (DeTrey‐Dentsply) without etching
Number of subjects: 60
Study: 9188761

Group type: EXPERIMENTAL
Intervention: Acute hyperglycemia (15 mmol/l)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Cholecystokinin (CCK) infusion (0.5 IDU/kg.h for 60 min) during hyperglycemia
Number of subjects: 7

Group type: COMPARATOR
Intervention: Cholecystokinin (CCK) infusion (0.5 IDU/kg.h for 60 min) during normoglycemia
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Basal and CCK-stimulated plasma PP concentrations during hyperglycemia
Number of subjects: 7
Study: 8442581

Group type: EXPERIMENTAL
Intervention: Theophylline (Uniphyllin Continus)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 3510591

Group type: EXPERIMENTAL
Intervention: 6 units of platelet concentrates (PLT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: 2 units of fresh frozen plasma (FFP)
Number of subjects: 33
Study: 29696311

Group type: EXPERIMENTAL
Intervention: E-monitoring counseling
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Nicotine patch plus nicotine gum
Number of subjects: 513

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 513
Study: 27622723

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 398

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 398
Study: 24820498

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound (Group B)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Real-time ultrasound guided biopsy (Group A)
Number of subjects: 79
Study: 23342881

Group type: EXPERIMENTAL
Intervention: Microtip catheter
Number of subjects: 122

Group type: COMPARATOR
Intervention: Air‐charged catheter
Number of subjects: 122
Study: 20593957

Group type: EXPERIMENTAL
Intervention: Cisplatin 40 mg/m2
Number of subjects: 140

Group type: COMPARATOR
Intervention: Cisplatin 20 mg/m2
Number of subjects: 140
Study: 18575626

Group type: EXPERIMENTAL
Intervention: Artesunate+amodiaquine (AS+AQ)
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Artesunate+chlorproguanil-dapsone (AS+CD)
Number of subjects: 534
Study: 16042882

Group type: EXPERIMENTAL
Intervention: famciclovir 500 mg tid
Number of subjects: 219

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 219
Study: 12594973

Group type: EXPERIMENTAL
Intervention: 80% grapeseed oil and 20% lavender oil in their bath for 14 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: grapeseed oil in their bath for 14 days
Number of subjects: 80
Study: 9841843

Group type: EXPERIMENTAL
Intervention: Hib conjugates administered to young children (two or three primary doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Herd immunity effect from Hib vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different Hib conjugates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three primary vaccine doses
Number of subjects: 0
Study: 7594337

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 26

Group type: COMPARATOR
Intervention: H2-receptor antagonist
Number of subjects: 26
Study: 2138180

Group type: EXPERIMENTAL
Intervention: Topical erythromycin plus zinc
Number of subjects: 103

Group type: COMPARATOR
Intervention: Topical 1% clindamycin phosphate (Cleocin‐T)
Number of subjects: 103
Study: 428219

Group type: EXPERIMENTAL
Intervention: Nova-T
Number of subjects: 1843

Group type: COMPARATOR
Intervention: Copper-T-200
Number of subjects: 1843
Study: 31062156

Group type: EXPERIMENTAL
Intervention: Incisionless fluorescent cholangiography (IFC)
Number of subjects: 51
Study: 31077181

Group type: EXPERIMENTAL
Intervention: Recent suicide attempts
Number of subjects: 288

Group type: COMPARATOR
Intervention: Duration of illness
Number of subjects: 288

Group type: COMPARATOR
Intervention: Low-density lipoprotein (LDL) cholesterol
Number of subjects: 288

Group type: COMPARATOR
Intervention: Total cholesterol
Number of subjects: 288

Group type: COMPARATOR
Intervention: Psychotic symptoms
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 288
Study: 28455510

Group type: EXPERIMENTAL
Intervention: NPK fertilization
Number of subjects: 3

Group type: COMPARATOR
Intervention: NP fertilization
Number of subjects: 3

Group type: COMPARATOR
Intervention: NK fertilization
Number of subjects: 3

Group type: COMPARATOR
Intervention: PK fertilization
Number of subjects: 3

Group type: COMPARATOR
Intervention: NP, NK, and PK fertilization
Number of subjects: 3
Study: 26198205

Group type: EXPERIMENTAL
Intervention: CTC
Number of subjects: 5384

Group type: COMPARATOR
Intervention: Colonoscopy
Number of subjects: 5384

Group type: COMPARATOR
Intervention: BE
Number of subjects: 5384
Study: 23250561

Group type: EXPERIMENTAL
Intervention: Pain and stress self-management intervention (PASS)
Number of subjects: 77
Study: 21360715

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg and itraconazole 200 mg combination
Number of subjects: 10

Group type: COMPARATOR
Intervention: Itraconazole 200 mg alone
Number of subjects: 10
Study: 19217538

Group type: EXPERIMENTAL
Intervention: Walking program for 2-9 weeks (Group A)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Walking program for 10-14 weeks (Group B)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Walking program for 15-94 weeks (Group C)
Number of subjects: 84
Study: 17786886

Group type: EXPERIMENTAL
Intervention: Lithium long-term treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other mood stabilizers and antidepressants
Number of subjects: 0
Study: 15252707

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine oestrogens plus 2.5 mg medroxyprogesterone acetate
Number of subjects: 15641

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15641
Study: 11384692

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate therapy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (normotensive women)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (newborns from normotensive women)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Preeclamptic women
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Newborns from preeclamptic women
Number of subjects: 25
Study: 9401132

Group type: EXPERIMENTAL
Intervention: Induced dysphoria (Study 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naturally occurring dysphoria (Study 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-conscious bias (14 ms exposure condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High trait anxiety (Study 2)
Number of subjects: 0
Study: 8495532

Group type: EXPERIMENTAL
Intervention: Soya milk preparations
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Hydrolyzed protein milk
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dietary change to soya milk
Number of subjects: 19
Study: 3446365

Group type: EXPERIMENTAL
Intervention: Dobutamine (10 micrograms.kg-1.min-1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Felodipine (5-10 mg)
Number of subjects: 20
Study: 2573003

Group type: EXPERIMENTAL
Intervention: 3 mg haloperidol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 125 mg Madopar
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31596866

Group type: EXPERIMENTAL
Intervention: Brief 3-week diet intervention (Diet Group)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control Group (habitual diet)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Diet Group
Number of subjects: 101
Study: 28086784

Group type: EXPERIMENTAL
Intervention: Modified Cardiac Rehabilitation Programme (MCRP)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Conventional Cardiac Rehabilitation Programme (CCRP)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study: 25226311

Group type: EXPERIMENTAL
Intervention: Citrulline malate (8 g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 12
Study: 23195033

Group type: COMPARATOR
Intervention: 480 mg choline/d
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 930 mg choline/d
Number of subjects: 26
Study: 21751250

Group type: EXPERIMENTAL
Intervention: Duloxetine 60/120 mg per day for 12 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (MD without cancer)
Number of subjects: 59
Study: 19288247

Group type: COMPARATOR
Intervention: Standard fluid regimen (group S, n=21)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Restricted fluid regimen (group R, n=20)
Number of subjects: 41
Study: 16728541

Group type: EXPERIMENTAL
Intervention: Paroxetine treatment
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: DII polymorphism (Thr92Ala)
Number of subjects: 98
Study: 15567471

Group type: EXPERIMENTAL
Intervention: 1.0 ppm chlorine exposure for 15 min
Number of subjects: 16

Group type: COMPARATOR
Intervention: Filtered air exposure for 15 min
Number of subjects: 16
Study: 10620131

Group type: EXPERIMENTAL
Intervention: Liposomes containing T4 endonuclease V
Number of subjects: 15

Group type: COMPARATOR
Intervention: Heat-inactivated enzyme (Control)
Number of subjects: 15
Study: 9370180

Group type: EXPERIMENTAL
Intervention: Replacement of aluminum kitchen utensils with stainless steel utensils for 3 months (study group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Aluminum kitchen utensils continued (control group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Study group patients with greater decrements of serum aluminum (>5.5 microg/L)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Study group patients with less decrements of serum aluminum (<5.5 microg/L)
Number of subjects: 42
Study: 8336377

Group type: EXPERIMENTAL
Intervention: Propranolol hydrochloride
Number of subjects: 602
Study: 3570859

Group type: EXPERIMENTAL
Intervention: Four types of milk with normal or low lactose and/or fat content, increasing amounts (125, 250, 500, 1000 ml/d)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Increasing amounts of milk (125, 250, 500, 1000 ml/d)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fat content in milk
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Individual differences
Number of subjects: 80
Study: 31554379

Group type: EXPERIMENTAL
Intervention: Self-monitoring quality of life intervention using the Care Notebook booklet
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 43
Study: 28024961

Group type: EXPERIMENTAL
Intervention: LCZ696 100mg bid (up-titrated to 200mg bid)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Enalapril 5mg bid (up-titrated to 10mg bid)
Number of subjects: 220
Study: 26805496

Group type: EXPERIMENTAL
Intervention: Empowerment program (8 weeks, 15 sessions)
Number of subjects: 37
Study: 24091268

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 21431329

Group type: EXPERIMENTAL
Intervention: Simultaneous administration of 200 mg mifepristone orally and 400 μg misoprostol vaginally
Number of subjects: 80

Group type: COMPARATOR
Intervention: Administration of 200 mg mifepristone orally and 400 μg misoprostol vaginally at 24-h interval
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Simultaneous administration of 200 mg mifepristone and 400 μg misoprostol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Administration of 200 mg mifepristone and 400 μg misoprostol at 24-h interval
Number of subjects: 80
Study: 18364535

Group type: EXPERIMENTAL
Intervention: Developmental group (DEV)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cross-validation group (C-V)
Number of subjects: 45
Study: 16792289

Group type: EXPERIMENTAL
Intervention: EEG/ECoG signals from nonparalyzed subjects
Number of subjects: 16

Group type: COMPARATOR
Intervention: EEG/ECoG signals from paralyzed subjects
Number of subjects: 16
Study: 12710222

Group type: EXPERIMENTAL
Intervention: Misinflected irregular verbs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher frequency of correct form
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misinflected form
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misinflected irregular verb
Number of subjects: 0
Study: 10640159

Group type: EXPERIMENTAL
Intervention: TCu-380A IUD
Number of subjects: 2748
Study: 8964633

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance assessment during hemodialysis
Number of subjects: 0
Study: 1839430

Group type: EXPERIMENTAL
Intervention: Heparan sulphate 100 mg per os, b.i.d.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mesoglycan 50 mg per os, t.i.d.
Number of subjects: 50
Study: 6756666

Group type: EXPERIMENTAL
Intervention: Salmon calcitonin SC 200 UI 6-hourly for 48 hours
Number of subjects: 25

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 25
Study: 30385039

Group type: EXPERIMENTAL
Intervention: Low-dose prednisone (0.5 mg/kg/day, maximum 40 mg/day) plus enteric-coated mycophenolate sodium 720 mg twice daily for 24 weeks
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional high-dose prednisone (1 mg/kg/day, maximum 80 mg/day) for 24 weeks
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Low-dose prednisone plus enteric-coated mycophenolate sodium
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional high-dose prednisone
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 116